Rising Demand for France Breast Cancer Therapeutics Market Key Players, Growth Analysis during 2019-2025
France breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 8.7% during the forecast period. The key factors that augmenting the market in this region include the prevalence of breast cancer, awareness program by the government and private organizations. Breast cancer is the most common cancer in women in this country. According to the WHO, about 56,162 new breast cancer cases and 13,353 mortalities estimated in 2018. Institute curie is a key centre for the treatment of breast cancer. The institute participating in more than 20 clinical trials for breast cancer on a variety of topics. The breast cancer screening program in France offers screening to women between 50 and 74 years of age which is covered by public health insurance.
To Request a Sample of our Report on France
Breast Cancer Therapeutics Market: https://www.omrglobal.com/request-sample/france-breast-cancer-therapeutics-market
France breast cancer therapeutics
market is segmented on the basis of therapy. The therapy segment is further
classified into chemotherapy, hormone therapy, targeted therapy, radiation therapy
and others (surgery). Among all therapies, chemotherapy market held the largest
market share in the France breast cancer therapeutics market. Chemotherapy is
most used when cancer in the lymph nodes and irrespective of tumor size or
menopausal status. Along with that it is used for the treatment of breast
cancer in premenopausal women and referred for those women who diagnosed with
early stage breast cancer for hormone receptor negative and HER2 positive
cancer. The types of chemotherapy include adjuvant chemotherapy and neoadjuvant
chemotherapy. The adjuvant chemotherapy is used to destroy cancer cells that
have been spread and not seen by the imaging tests. This method helps in
reducing the cancer cells that form a new tumor in the other place of the body.
Adjuvant chemotherapy reduces the risk of breast cancer coming back.
Neoadjuvant chemotherapy can be used to reduce the size of the tumor, so it can
be removed with less widespread surgery.
(Get 15% Discount on Buying this Report)
A
full Report of France Breast Cancer Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/france-breast-cancer-therapeutics-market
France Breast Cancer Therapeutics Market Segmentation
By Therapeutics
·
Chemotherapy
·
Hormone Therapy
·
Targeted Therapy
·
Others (Radiation Therapy, Surgery)
Company Profiles
·
AbbVie Inc.
·
AstraZeneca PLC
·
Astellas Pharma Inc.
·
Bayer AG
·
GlaxoSmithKline PLC
·
Mylan NV
·
Merck & Co., Inc.
·
Novartis International AG
·
F. Hoffmann-La Roche AG
·
Sanofi S.A.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment